Knollwood Investment Advisory’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,500
Closed -$295K – 306
2026
Q1
$295K Hold
2,500
– – 0.03% 269
2025
Q4
$410K Hold
2,500
– – 0.04% 243
2025
Q3
$334K Hold
2,500
– – 0.03% 301
2025
Q2
$311K Hold
2,500
– – 0.03% 306
2025
Q1
$318K Hold
2,500
– – 0.04% 300
2024
Q4
$360K Hold
2,500
– – 0.04% 287
2024
Q3
$372K Hold
2,500
– – 0.04% 298
2024
Q2
$315K Buy
+2,500
New +$392K 0.04% 306

Other funds holding RGEN

Knollwood Investment Advisory's RGEN Position: Q2 2026 in Review

Knollwood Investment Advisory sold out of Repligen (RGEN) in Q2 2026, closing a stake of 2,500 shares — an estimated $295K sold.

Knollwood Investment Advisory first reported a position in RGEN in Q2 2024 and held it in 8 quarters. The position peaked at $410K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Knollwood Investment Advisory reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Knollwood Investment Advisory sold 2,500 Repligen shares in Q2 2026, an estimated $295K.
  • Knollwood Investment Advisory first reported a position in Repligen in Q2 2024 and held it in 8 quarters.
  • Knollwood Investment Advisory's Repligen position peaked at $410K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.